Status unknownNCT00573807Updated Jan 5, 2009

Energy Specific Far Infrared Radiation Treatment for Sciatica

A Phase 1 interventional study of Far Infrared Radiation (5μm to 20μm wavelength) in Sciatica, sponsored by GAAD Medical Research Institute Inc.. Status unknown at 1 site in Canada. Per ClinicalTrials.gov, last updated 2009-01-05.

Sponsored by GAAD Medical Research Institute Inc. · Phase 1, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jan 2009), so the status shown — last known as Active, not recruiting — may be out of date.

Phase: Phase 1
Study type: Interventional
Enrollment: 2
Allocation: Non-randomized
Sex: All

Study summary

A preliminary study to determine the use of far infrared radiation for the treatment of back pain

Read the detailed description

Sciatica is created by joint misalignment, muscle spasm and inflammation. Generally, sciatica is a combination of lower back pain, pain radiating into the buttock and possibly down the leg.

Far infrared radiation of the sciatic nerve, coupled with the stretching of the spinal cord, is a promising non-invasive method for treating sciatica.

Conditions studied

Sciatica

Browse trials for

Keywords

Neuralgia, Sciatic
Sciatic Neuralgia
Sciatica, Bilateral
Lower back pain

In context

Sciatica

143 studies on the registry are indexed under Sciatica; 29 are open to participants now.

This study's planned enrollment of 2 is below the median of 66 across 114 interventional studies indexed under Sciatica.

Browse Sciatica studies →

Lead sponsor

GAAD Medical Research Institute Inc. is the lead sponsor of 22 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

Who can participate

Ages eligible: Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible: All
Accepts healthy volunteers: No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Persons with lower back pain

Exclusion criteria

Exclusion Criteria:

None

Study design

Phase: Phase 1
Primary purpose: Treatment
Allocation: Non-randomized
Intervention model: Single group
Masking: None (open label)
Enrollment: 2 participants (estimated)

Study arms

Other
1
Radiation: Far Infrared Radiation (5μm to 20μm wavelength)

Interventions

RadiationFar Infrared Radiation (5μm to 20μm wavelength)
Far Infrared Radiation (5μm to 20μm wavelength)for 30 to 40 minutes per treatment session.

What researchers measure

Primary outcomes

The primary end point is to determine the therapeutic effects of far infrared radiation on the Sciatic nerve.
Time frame: 2 years and 6 months

Secondary outcomes

Far infrared treatment for other pain syndromes
Time frame: 2 years and 6 months

Study locations

1 site

The Centre for Incurable Diseases
Toronto, Ontario M4V 1L5, Canada

Timeline

Tracking since Sep 25, 2026

Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jan 2006, a primary completion of Mar 2008 and a completion of Dec 2008. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered: Dec 12, 2007
First posted: Dec 14, 2007
Start: Jan 2006
Primary completionEst.: Mar 2008
CompletionEst.: Dec 2008
Last update: Jan 5, 2009

What these dates mean

Start.: When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.: When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.: When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.: Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.

No changes since tracking began. The registry record was last updated on Jan 5, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗

Registry details

Key details

Study ID: NCT00573807
Lead sponsor: GAAD Medical Research Institute Inc.
First posted: Dec 14, 2007
Start date: Jan 2006
Primary completion: Mar 2008 (estimated)
Completion: Dec 2008 (estimated)
Last update: Jan 5, 2009

Study contacts

Ken Nedd, M.D.

study director · GAAD Medical Research Institute Inc.

Kwasi Donyina, Ph.D.

study chair · GAAD Medical Research Institute Inc.

Oversight

Data monitoring committee: Yes

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Sciatica →

Other studies from this sponsor

GAAD Medical Research Institute Inc.

Start the discussion